UA93355C2 - Композиция субероиланилид-гидроксаминовой кислоты и способы ee получения - Google Patents

Композиция субероиланилид-гидроксаминовой кислоты и способы ee получения

Info

Publication number
UA93355C2
UA93355C2 UAA200701731A UAA200701731A UA93355C2 UA 93355 C2 UA93355 C2 UA 93355C2 UA A200701731 A UAA200701731 A UA A200701731A UA A200701731 A UAA200701731 A UA A200701731A UA 93355 C2 UA93355 C2 UA 93355C2
Authority
UA
Ukraine
Prior art keywords
hydroxamic acid
suberoylanilide hydroxamic
formulation
producing same
present
Prior art date
Application number
UAA200701731A
Other languages
English (en)
Ukrainian (uk)
Inventor
Джинни Чоу Вонг
Аарон C. Коут
Эрик A. Дайнеманн
Кимберли Галлахер
Крейг Икеда
Джастин Моузер
Паволь Райньяк
Роберт A. Рид
Синди Старбак
Хсиен-Хсин Тунг
Циньси Ван
Бенджамин Макс Коэн
Винсент P. Каподанно
Брайан Селл
Томас A. Миллер
Original Assignee
Mepk Шарп Энд Доме Корп.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mepk Шарп Энд Доме Корп. filed Critical Mepk Шарп Энд Доме Корп.
Publication of UA93355C2 publication Critical patent/UA93355C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Данное изобретение касается фармацевтической композиции с конкретным профилем растворимости, которая в качестве активного ингредиента содержит субероиланилид-гидроксаминовую кислоту с конкретным распределением размеров частичек. Данное изобретение также касается способа получения указанной фармацевтической композиции.
UAA200701731A 2005-05-20 2006-05-16 Композиция субероиланилид-гидроксаминовой кислоты и способы ee получения UA93355C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68287505P 2005-05-20 2005-05-20

Publications (1)

Publication Number Publication Date
UA93355C2 true UA93355C2 (ru) 2011-02-10

Family

ID=37946173

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200701731A UA93355C2 (ru) 2005-05-20 2006-05-16 Композиция субероиланилид-гидроксаминовой кислоты и способы ee получения

Country Status (7)

Country Link
EP (1) EP2229941A1 (ru)
CN (1) CN101080223B (ru)
AR (1) AR095159A2 (ru)
NO (1) NO20070952L (ru)
RU (1) RU2354362C2 (ru)
UA (1) UA93355C2 (ru)
ZA (1) ZA200700636B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883851B2 (en) 2008-10-15 2014-11-11 Generics [Uk] Limited Process for the preparation of vorinostat
JP2012509929A (ja) * 2008-11-26 2012-04-26 ジェネリクス・（ユーケー）・リミテッド 多型
CN102344392B (zh) * 2010-08-03 2015-05-27 杭州容立医药科技有限公司 一种蛋白脱乙酰酶抑制剂伏立诺他的精制方法
CN102643214B (zh) * 2011-02-21 2016-08-03 杭州容立医药科技有限公司 伏立诺他ⅰ晶形大晶粒的制备方法及制剂
CN103159646B (zh) * 2013-03-19 2014-10-22 广东药学院 一种异羟肟酸类化合物及其制备方法和应用
CN107362148B (zh) * 2017-07-27 2020-04-21 东曜药业有限公司 一种治疗肿瘤的药物组合物及其制备方法和应用
CN108929246B (zh) * 2018-07-09 2021-07-02 湖南中医药大学 一种固态法制备羟肟酸类衍生物的方法
CN110283102B (zh) * 2019-05-31 2022-09-27 宿州亿帆药业有限公司 一种伏林司他ⅰ晶型的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
CN101259120B (zh) * 2002-03-04 2012-07-04 Hdac默克研究有限责任公司 辛二酰苯胺异羟肟酸或其可药用盐在制备诱导末期分化的药物的用途
US7456219B2 (en) * 2002-03-04 2008-11-25 Merck Hdac Research, Llc Polymorphs of suberoylanilide hydroxamic acid

Also Published As

Publication number Publication date
AR095159A2 (es) 2015-09-30
ZA200700636B (en) 2008-10-29
CN101080223B (zh) 2015-02-11
EP2229941A1 (en) 2010-09-22
RU2007106072A (ru) 2008-08-27
RU2354362C2 (ru) 2009-05-10
NO20070952L (no) 2007-03-20
CN101080223A (zh) 2007-11-28

Similar Documents

Publication Publication Date Title
NO20073959L (no) Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2010088000A3 (en) Antifibrotic compounds and uses thereof
MY174452A (en) Substituted piperidines that increase p53 activity and the uses thereof
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
WO2007086078A3 (en) Novel pharmaceutical compositions and process of preparation thereof
ZA200805563B (en) Stable pharmaceutical formulation of an acid labile compound and process for preparing the same
WO2017177004A8 (en) Tertiary amides and method of use
EP1993567A4 (en) PER OS ADMINISTRABLE GALLIUM PREPARATIONS AND METHODS OF USE
CR8912A (es) Formulaciones de acido hidroxamico suberoilanilida y procedimientos para la produccion de las mismas
WO2010070677A3 (en) A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof
EP4477222A3 (en) Crystalline 4-(5-chloro-2-isopropylaminopyridin-4-yl)-1h-pyrrole-2-carboxylic acid [1-(3-chlorophenyl)-2-hydroxyethyl]amide hydrochloride salt
NZ591204A (en) Pharmaceutical compositions and methods for stabilizing the same
NO20070952L (no) Formuleringer av suberoylanilidhydroksaminsyre og fremgangsmate for fremstilling av slike
PH12014502407A1 (en) New alfentanil composition for the treatment of acute pain
WO2007110765A3 (en) Processes for the preparation of octreotide
EP4342542A3 (en) Combination of regorafenib and nivolumab for treating cancer
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions
HUP0401525A2 (en) Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them
MX2009005804A (es) Composicion farmaceutica de memantina.
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст
UA95274C2 (ru) Твердый фармацевтический препарат, содержащий ирбесартан, и способы его изготовления
WO2006110810A3 (en) Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine